Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10691) 10691
Publication (683) 683
Book Review (68) 68
Book / eBook (25) 25
Book Chapter (24) 24
Magazine Article (12) 12
Dissertation (6) 6
Web Resource (4) 4
Conference Proceeding (2) 2
Reference (2) 2
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9834) 9834
female (7062) 7062
middle aged (5019) 5019
male (4689) 4689
index medicus (4268) 4268
surgery (4028) 4028
adult (3912) 3912
aged (3897) 3897
oncology (3595) 3595
peritoneal neoplasms - secondary (3188) 3188
peritoneal neoplasms - surgery (3083) 3083
cancer (2630) 2630
peritoneal neoplasms - pathology (2441) 2441
prognosis (1990) 1990
chemotherapy (1980) 1980
combined modality therapy (1660) 1660
peritoneal neoplasms - drug therapy (1646) 1646
treatment outcome (1573) 1573
retrospective studies (1523) 1523
neoplasm staging (1504) 1504
peritoneal neoplasms - therapy (1471) 1471
peritoneal neoplasms - diagnosis (1405) 1405
cytoreductive surgery (1387) 1387
aged, 80 and over (1260) 1260
peritoneal carcinomatosis (1222) 1222
survival rate (1217) 1217
carcinoma (1198) 1198
medicine & public health (1192) 1192
ovarian neoplasms - pathology (1192) 1192
antineoplastic combined chemotherapy protocols - therapeutic use (1185) 1185
stomach neoplasms - pathology (1165) 1165
metastasis (1151) 1151
follow-up studies (1105) 1105
survival (1081) 1081
obstetrics & gynecology (1069) 1069
ovarian cancer (1050) 1050
peritoneal neoplasms - mortality (946) 946
hyperthermia, induced (940) 940
tomography, x-ray computed (932) 932
ovarian neoplasms - surgery (887) 887
tumors (875) 875
animals (858) 858
analysis (821) 821
care and treatment (821) 821
gastroenterology & hepatology (818) 818
stomach neoplasms - surgery (778) 778
diagnosis, differential (777) 777
laparoscopy (774) 774
surgical oncology (716) 716
colorectal neoplasms - pathology (711) 711
chemotherapy, adjuvant (705) 705
colorectal cancer (704) 704
lymphatic metastasis (695) 695
management (687) 687
health aspects (676) 676
carcinomatosis (672) 672
liver neoplasms - secondary (667) 667
hyperthermic intraperitoneal chemotherapy (646) 646
intraperitoneal chemotherapy (640) 640
survival analysis (638) 638
recurrence (622) 622
prospective studies (616) 616
peritoneal neoplasms - diagnostic imaging (612) 612
colorectal-cancer (593) 593
diagnosis (592) 592
adolescent (588) 588
research (577) 577
gastric cancer (576) 576
infusions, parenteral (575) 575
ovarian neoplasms - drug therapy (575) 575
antineoplastic agents - administration & dosage (573) 573
pathology (560) 560
peritoneum (545) 545
antineoplastic agents - therapeutic use (543) 543
neoplasm invasiveness (533) 533
risk factors (533) 533
adenocarcinoma (524) 524
peritoneal neoplasms - complications (515) 515
disease-free survival (511) 511
young adult (505) 505
adenocarcinoma - surgery (501) 501
stomach cancer (499) 499
immunohistochemistry (491) 491
pseudomyxoma peritonei (481) 481
cisplatin (473) 473
adenocarcinoma - secondary (471) 471
hematology, oncology and palliative medicine (471) 471
time factors (470) 470
mesothelioma (451) 451
cisplatin - administration & dosage (450) 450
adenocarcinoma - pathology (447) 447
mortality (445) 445
mice (442) 442
carcinoma - surgery (432) 432
hipec (432) 432
gastrectomy (420) 420
stomach neoplasms - drug therapy (414) 414
chemotherapy, cancer, regional perfusion (390) 390
mesentery (381) 381
morbidity (381) 381
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (10) 10
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9179) 9179
Japanese (420) 420
French (309) 309
German (224) 224
Italian (126) 126
Spanish (119) 119
Russian (101) 101
Chinese (86) 86
Polish (36) 36
Romanian (24) 24
Dutch (20) 20
Hungarian (20) 20
Czech (16) 16
Bulgarian (13) 13
Korean (11) 11
Portuguese (11) 11
Danish (10) 10
Serbian (10) 10
Croatian (8) 8
Ukrainian (6) 6
Hebrew (5) 5
Norwegian (5) 5
Swedish (4) 4
Finnish (2) 2
Turkish (2) 2
Arabic (1) 1
Icelandic (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
by McCluggage, W. Glenn and Judge, Meagan J and Clarke, Blaise A and Davidson, Ben and Gilks, C. Blake and Hollema, Harry and Ledermann, Jonathan A and Matias-Guiu, Xavier and Mikami, Yoshiki and Stewart, Colin J. R and Vang, Russell and Hirschowitz, Lynn and International Collaboration on Cancer Reporting
Modern Pathology, ISSN 0893-3952, 08/2015, Volume 28, Issue 8, pp. 1101 - 1122
A comprehensive pathological report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are... 
PATHOLOGY | Predictive Value of Tests | Humans | Ovarian Neoplasms - pathology | Immunohistochemistry - standards | Carcinoma - chemistry | Peritoneal Neoplasms - chemistry | Ovarian Neoplasms - genetics | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Fallopian Tube Neoplasms - chemistry | Fallopian Tube Neoplasms - genetics | Female | Molecular Diagnostic Techniques - standards | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Carcinoma - pathology | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Carcinoma - drug therapy | Peritoneal Neoplasms - pathology | Pathology, Clinical - standards | Diagnosis, Differential | Ovarian Neoplasms - chemistry | Biopsy - standards | Biomarkers, Tumor - analysis | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Fallopian Tube Neoplasms - pathology | Fallopian Tube Neoplasms - surgery | Peritoneal Neoplasms - genetics | Carcinoma - genetics | Research Design - standards | Biomarkers, Tumor - genetics | Neoplasm Staging | Ovarian Neoplasms - surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text A multicentric trial (Olympia–MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer
by Fagotti, Anna, PhD and Vizzielli, Giuseppe, MD and De Iaco, Pierandrea, MD and Surico, Daniela, MD and Buda, Alessandro, MD and Mandato, Vincenzo Dario, PhD and Petruzzelli, Francesco, MD and Ghezzi, Fabio, MD and Garzarelli, Salvatore, MD and Mereu, Liliana, MD and Viganò, Riccardo, MD and Tateo, Saverio, MD and Fanfani, Francesco, MD and Scambia, Giovanni, MD
American Journal of Obstetrics and Gynecology, ISSN 0002-9378, 2013, Volume 209, Issue 5, pp. 462.e1 - 462.e11
Objective The objective of the study was to prospectively evaluate the accuracy of laparoscopy performed in satellite centers (SCs) to describe intraabdominal... 
Obstetrics and Gynecology | laparoscopy | specificity | accuracy | ovarian cancer | carcinomatosis | SURVIVAL | CYTOREDUCTIVE SURGERY | SCORE | PREDICT | VALIDATION | CARCINOMA | OBSTETRICS & GYNECOLOGY | Predictive Value of Tests | Gastrointestinal Neoplasms - secondary | Prospective Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Staging - methods | Laparoscopy - methods | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Carcinoma - secondary | Peritoneal Neoplasms - secondary | Peritoneal Neoplasms - pathology | Carcinoma - surgery | Peritoneal Neoplasms - surgery | Gastrointestinal Neoplasms - surgery | Carcinoma - diagnosis | Liver Neoplasms - surgery | Gastrointestinal Neoplasms - diagnosis | Liver Neoplasms - diagnosis | Aged | Cohort Studies | Ovarian Neoplasms - surgery | Laparoscopic surgery | Laparoscopy | Ovarian cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Impact of Complete Cytoreduction Leaving No Gross Residual Disease Associated with Radical Cytoreductive Surgical Procedures on Survival in Advanced Ovarian Cancer
by Chang, Suk-Joon and Bristow, Robert E and Ryu, Hee-Sug
Annals of Surgical Oncology, ISSN 1068-9265, 12/2012, Volume 19, Issue 13, pp. 4059 - 4067
To analyze the impact of radical cytoreductive surgery—as part of primary tumor debulking—on the amount of residual tumor and survival in patients with... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | SURGERY | PROGNOSTIC-FACTOR | ONCOLOGY | RESECTION | CARCINOMA | Prognosis | Follow-Up Studies | Neoplasm, Residual - surgery | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Gynecologic Surgical Procedures | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Cystadenocarcinoma, Serous - drug therapy | Neoplasm Recurrence, Local - surgery | Peritoneal Neoplasms - drug therapy | Neoplasm Grading | Adenocarcinoma, Mucinous - surgery | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Neoplasm, Residual - mortality | Adenocarcinoma, Mucinous - drug therapy | Ovarian Neoplasms - drug therapy | Adenocarcinoma, Clear Cell - surgery | Peritoneal Neoplasms - surgery | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Cystadenocarcinoma, Serous - surgery | Adenocarcinoma, Mucinous - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endometrial Neoplasms - surgery | Neoplasm, Residual - drug therapy | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - drug therapy | Aged | Neoplasm Staging | Adenocarcinoma, Clear Cell - drug therapy | Ovarian Neoplasms - surgery | Chemotherapy | Analysis | Ovarian cancer | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by van Driel, Willemien J and Koole, Simone N and Sikorska, Karolina and Schagen van Leeuwen, Jules H and Schreuder, Henk W.R and Hermans, Ralph H.M and de Hingh, Ignace H.J.T and van der Velden, Jacobus and Arts, Henriëtte J and Massuger, Leon F.A.G and Aalbers, Arend G.J and Verwaal, Victor J and Kieffer, Jacobien M and Van de Vijver, Koen K and van Tinteren, Harm and Aaronson, Neil K and Sonke, Gabe S
The New England Journal of Medicine, ISSN 0028-4793, 01/2018, Volume 378, Issue 3, pp. 230 - 240
The addition of HIPEC with cisplatin to cytoreductive surgery in stage III ovarian cancer resulted in recurrence-free survival that was longer by 3.5 months... 
GYNECOLOGIC-ONCOLOGY | TRIAL | MEDICINE, GENERAL & INTERNAL | CYTOREDUCTIVE SURGERY | NEOADJUVANT CHEMOTHERAPY | CISPLATIN | PHARMACOKINETICS | PERITONEAL CARCINOMATOSIS | OUTCOMES | Humans | Middle Aged | Carboplatin - administration & dosage | Combined Modality Therapy | Ovarian Neoplasms - mortality | Cytoreduction Surgical Procedures | Neoplasms, Glandular and Epithelial - surgery | Cisplatin - administration & dosage | Neoplasms, Glandular and Epithelial - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hyperthermia, Induced | Intention to Treat Analysis | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Female | Aged | Neoplasm Staging | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Hyperthermic intraperitoneal chemotherapy | Cancer patients | Care and treatment | Usage | Ovarian cancer | Clinical trials | Oncology | Patients | Survival | Cisplatin | Cancer surgery | Side effects | Chemotherapy | Womens health | Surgery | Paclitaxel | Carboplatin | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by Terence C. Chua and Brendan J. Moran and Paul H. Sugarbaker and Edward A. Levine and Olivier Glehen and François N. Gilly and Dario Baratti and Marcello Deraco and Dominique Elias and Armando Sardi and Winston Liauw and Tristan D. Yan and Pedro Barrios and Alberto Gómez Portilla and Ignace H.J.T. de Hingh and Wim P. Ceelen and Joerg O. Pelz and Pompiliu Piso and Santiago González-Moreno and Kurt Van Der Speeten and David L. Morris
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 20, pp. 2449 - 2456
Purpose Pseudomyxoma peritonei (PMP) originating from an appendiceal mucinous neoplasm remains a biologically heterogeneous disease. The purpose of our study... 
SURVIVAL | ONCOLOGY | COLORECTAL-CANCER | DISSEMINATION | SYSTEMIC CHEMOTHERAPY | MUCINOUS NEOPLASMS | RANDOMIZED-TRIAL | CARCINOMATOSIS | EXPERIENCE | SINGLE-INSTITUTION | CLINICOPATHOLOGICAL ANALYSIS | Pseudomyxoma Peritonei - surgery | Humans | Middle Aged | Peritoneal Neoplasms - surgery | Injections, Intraperitoneal | Male | Survival Rate | Combined Modality Therapy | Peritoneal Neoplasms - mortality | Pseudomyxoma Peritonei - drug therapy | Young Adult | Disease-Free Survival | Peritoneal Neoplasms - drug therapy | Pseudomyxoma Peritonei - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged, 80 and over | Adult | Female | Aged | Appendiceal Neoplasms - pathology | Hyperthermia, Induced - methods | Peritoneal Neoplasms - therapy | Peritoneal Neoplasms - secondary
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
by Chi, Dennis S and Musa, Fernanda and Dao, Fanny and Zivanovic, Oliver and Sonoda, Yukio and Leitao, Mario M and Levine, Douglas A and Gardner, Ginger J and Abu-Rustum, Nadeem R and Barakat, Richard R
Gynecologic Oncology, ISSN 0090-8258, 2011, Volume 124, Issue 1, pp. 10 - 14
Abstract Objective The recent EORTC-NCIC randomized trial comparing primary debulking surgery (PDS) to neoadjuvant chemotherapy (NACT) in advanced epithelial... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Neoadjuvant chemotherapy | Cytoreduction | Primary peritoneal cancer | Primary debulking surgery | Fallopian tube cancer | Ovarian cancer | SURVIVAL | INTERVAL | METAANALYSIS | GYNECOLOGIC-ONCOLOGY-GROUP | PRIMARY CYTOREDUCTIVE SURGERY | CANCER | TUMORS | OBSTETRICS & GYNECOLOGY | ONCOLOGY | EPITHELIAL OVARIAN | PROGRESSION | Humans | Middle Aged | Ovarian Neoplasms - pathology | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Adjuvant | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Peritoneal Neoplasms - surgery | Fallopian Tube Neoplasms - pathology | Neoplasms, Glandular and Epithelial - surgery | Randomized Controlled Trials as Topic | Disease-Free Survival | Fallopian Tube Neoplasms - surgery | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Aged | Neoplasm Staging | Cohort Studies | Ovarian Neoplasms - surgery | Care and treatment | Carcinoma | Analysis | Adjuvant treatment | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Are all pelvic (Nonuterine) serous carcinomas of tubal origin?
by Przybycin, Christopher G and Kurman, Robert J and Ronnett, Brigitte M and Shih, Ie-Ming and Vang, Russell
American Journal of Surgical Pathology, ISSN 0147-5185, 10/2010, Volume 34, Issue 10, pp. 1407 - 1416
It has been proposed that the presence of tubal intraepithelial carcinoma (TIC), in association with one-third to nearly half of pelvic serous carcinomas, is... 
ovary | serous carcinoma | fallopian tube | tubal intraepithelial carcinoma | TIC | SURGERY | PRECURSOR | MIXED MULLERIAN TUMOR | MUTATION CARRIERS | PERITONEAL | FALLOPIAN-TUBE | OOPHORECTOMY | OVARIAN-CANCER | PATHOLOGY | INTRAEPITHELIAL CARCINOMA | PATHOGENESIS | SPECIMENS | Peritoneal Neoplasms - pathology | Pelvic Neoplasms - surgery | Carcinoma in Situ - pathology | Humans | Peritoneal Neoplasms - surgery | Ovarian Neoplasms - pathology | Fallopian Tube Neoplasms - pathology | Fallopian Tubes - surgery | Cystadenocarcinoma, Serous - pathology | Cystadenocarcinoma, Serous - surgery | Fallopian Tubes - pathology | Carcinoma in Situ - surgery | Fallopian Tube Neoplasms - surgery | Female | Ovarian Neoplasms - surgery | Pelvic Neoplasms - pathology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center
by Norlén, Olov and Stålberg, Peter and Öberg, Kjell and Eriksson, John and Hedberg, Jakob and Hessman, Ola and Janson, Eva Tiensuu and Hellman, Per and Åkerström, Göran and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Gastrointestinalkirurgi and Uppsala universitet and Endokrinkirurgi and Institutionen för medicinska vetenskaper and Institutionen för kirurgiska vetenskaper
World Journal of Surgery, ISSN 0364-2313, 6/2012, Volume 36, Issue 6, pp. 1419 - 1431
Small intestinal neuroendocrine tumors (SI-NETs) are uncommon, with an annual incidence of about 1 per 100,000 individuals. The primary tumor (PT) is generally... 
Medicine & Public Health | Cardiac Surgery | Surgery | Abdominal Surgery | Vascular Surgery | Thoracic Surgery | General Surgery | LIVER METASTASES | SURVIVAL | SURGERY | INTERFERON | MANAGEMENT | NEURO ENDOCRINE TUMORS | PROGNOSTIC-FACTORS | MIDGUT CARCINOID-TUMORS | PERITONEAL CARCINOMATOSIS | COMBINATION | SURGICAL-TREATMENT | Lymph Node Excision | Multivariate Analysis | Prognosis | Follow-Up Studies | Intestine, Small - pathology | Humans | Middle Aged | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Female | Retrospective Studies | Liver Neoplasms - secondary | Peritoneal Neoplasms - secondary | Neuroendocrine Tumors - pathology | Intestinal Neoplasms - surgery | Intestinal Neoplasms - mortality | Peritoneal Neoplasms - surgery | Liver Neoplasms - surgery | Combined Modality Therapy | Lymphatic Metastasis | Peritoneal Neoplasms - mortality | Intestinal Neoplasms - pathology | Intestinal Neoplasms - therapy | Intestine, Small - surgery | Neuroendocrine Tumors - mortality | Survival Analysis | Neuroendocrine Tumors - surgery | Aged | Neuroendocrine Tumors - therapy | Laparotomy | Peritoneal Neoplasms - therapy | Liver cancer | Metastasis | Heart diseases | Health aspects | Coronary heart disease | Analysis | Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: Impact on prognosis in a single institution experience
by Fagotti, A and Vizzielli, G and Fanfani, F and Costantini, B and Ferrandina, G and Gallotta, V and Gueli Alletti, S and Tortorella, L and Scambia, G
Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 131, Issue 2, pp. 341 - 346
Abstract Objective To evaluate the prognostic impact of routinely use of staging laparoscopy (S-LPS) in patients with primary advanced epithelial ovarian... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Cytoreduction | Laparoscopy | Carcinosis | Ovarian cancer | SURVIVAL | GYNECOLOGIC-ONCOLOGY-GROUP | PRIMARY CYTOREDUCTIVE SURGERY | PREDICTION | OBSTETRICS & GYNECOLOGY | TRIAL | NEOADJUVANT CHEMOTHERAPY | ONCOLOGY | DISEASE | CARCINOMA | Humans | Middle Aged | Ovarian Neoplasms - pathology | Peritoneal Neoplasms - diagnosis | Neoplasm Staging - methods | Laparoscopy - methods | Peritoneal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Chemotherapy, Adjuvant | Neoplasms, Glandular and Epithelial - diagnosis | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Peritoneal Neoplasms - pathology | Neoplasms, Glandular and Epithelial - pathology | Ovarian Neoplasms - diagnosis | Peritoneal Neoplasms - surgery | Fallopian Tube Neoplasms - pathology | Neoplasms, Glandular and Epithelial - surgery | Randomized Controlled Trials as Topic | Disease-Free Survival | Algorithms | Fallopian Tube Neoplasms - diagnosis | Fallopian Tube Neoplasms - surgery | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Aged | Ovarian Neoplasms - surgery | Laparoscopic surgery
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Fluorescent‐guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent‐guided surgery in colorectal and pancreatic cancer
by Vuijk, Floris A and Hilling, Denise E and Mieog, J. Sven D and Vahrmeijer, Alexander L
Journal of Surgical Oncology, ISSN 0022-4790, 08/2018, Volume 118, Issue 2, pp. 315 - 323
Sentinel lymph node procedures for gastric cancer resections using indocyanine green (ICG) linked to Nanocoll outperformed normal ICG but did not provide... 
pancreatic neoplasm | molecular imaging | lymphatic metastasis | rectal neoplasm | SURGERY | INDOCYANINE GREEN | INTRAPERITONEAL CHEMOTHERAPY | R1 RESECTION | CYTOREDUCTIVE SURGERY | RISK-FACTORS | PERITONEAL CARCINOMATOSIS | LONG-TERM OUTCOMES | COLON-CANCER | CIRCUMFERENTIAL RESECTION MARGINS | ONCOLOGY | STAGING LAPAROSCOPY | Colorectal Neoplasms - surgery | Digestive System Neoplasms - metabolism | Pancreatic Neoplasms - metabolism | Humans | Stomach Neoplasms - metabolism | Stomach Neoplasms - pathology | Carcinoembryonic Antigen - metabolism | Digestive System Neoplasms - diagnostic imaging | Digestive System Neoplasms - pathology | Sentinel Lymph Node - metabolism | Colorectal Neoplasms - metabolism | Optical Imaging - methods | Stomach Neoplasms - diagnostic imaging | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Sentinel Lymph Node - diagnostic imaging | Surgery, Computer-Assisted - methods | Colorectal Neoplasms - diagnostic imaging | Lymphatic Metastasis | Sentinel Lymph Node - pathology | Sentinel Lymph Node - surgery | Digestive System Neoplasms - surgery | Colorectal Neoplasms - pathology | Stomach Neoplasms - surgery | Pancreatic Neoplasms - diagnostic imaging | Diagnosis | Stomach cancer | CEA (Oncology) | Pancreatic cancer | Colorectal cancer | Cancer | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Preoperative Serum Carcinoembryonic Antigen Level as a Predictive Factor of Recurrence After Curative Resection of Colorectal Cancer
by Takagawa, Ryo and Fujii, Syoichi and Ohta, Mitsuyoshi and Nagano, Yasuhiko and Kunisaki, Chikara and Yamagishi, Shigeru and Osada, Shunichi and Ichikawa, Yasushi and Shimada, Hiroshi
Annals of Surgical Oncology, ISSN 1068-9265, 12/2008, Volume 15, Issue 12, pp. 3433 - 3439
We evaluated the prognostic value of the preoperative serum carcinoembryonic antigen (CEA) level in patients with colorectal cancer (CRC).The study group... 
Oncology | Medicine & Public Health | Surgical Oncology | Surgery | CAPECITABINE | SURGERY | III COLON-CANCER | COST-EFFECTIVENESS | ONCOLOGY | DISEASE | ADJUVANT TREATMENT | RANDOMIZED-TRIAL | OXALIPLATIN | PROGNOSTIC-SIGNIFICANCE | FLUOROURACIL | CEA | Colorectal Neoplasms - surgery | Prognosis | Carcinoembryonic Antigen - blood | Peritoneal Neoplasms - blood | Humans | Middle Aged | Bone Neoplasms - secondary | Male | Neoplasm Recurrence, Local - surgery | Brain Neoplasms - surgery | Liver Neoplasms - blood | Brain Neoplasms - secondary | Lung Neoplasms - secondary | Brain Neoplasms - blood | Aged, 80 and over | Adult | Female | Bone Neoplasms - blood | Liver Neoplasms - secondary | Neoplasm Recurrence, Local - blood | Peritoneal Neoplasms - secondary | Colorectal Neoplasms - blood | Neoplasm Invasiveness | Peritoneal Neoplasms - surgery | Liver Neoplasms - surgery | Survival Rate | Lymphatic Metastasis | Neoplasm Recurrence, Local - diagnosis | Bone Neoplasms - surgery | Preoperative Care | Biomarkers, Tumor - blood | Lung Neoplasms - surgery | Aged | Lung Neoplasms - blood | Colorectal Neoplasms - pathology | Oncology, Experimental | Analysis | Colorectal cancer | Metastasis | Research | CEA (Oncology) | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602
by Onda, Takashi and Satoh, Toyomi and Saito, Toshiaki and Kasamatsu, Takahiro and Nakanishi, Toru and Nakamura, Kenichi and Wakabayashi, Masashi and Takehara, Kazuhiro and Saito, Motoaki and Ushijima, Kimio and Kobayashi, Hiroaki and Kawana, Kei and Yokota, Harushige and Takano, Masashi and Takeshima, Nobuhiro and Watanabe, Yoh and Yaegashi, Nobuo and Konishi, Ikuo and Kamura, Toshiharu and Yoshikawa, Hiroyuki and Japan Clin Oncology Grp and Japan Clinical Oncology Group
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 64, pp. 22 - 31
Abstract Background We conducted a phase III, non-inferiority trial comparing upfront primary debulking surgery (PDS) and interval debulking surgery (IDS)... 
Hematology, Oncology and Palliative Medicine | Neoadjuvant therapy | Interval debulking surgery | Ovarian neoplasms | Primary debulking surgery | SURVIVAL | ONCOLOGY | CARCINOMA | Peritoneal Neoplasms - pathology | Humans | Middle Aged | Peritoneal Neoplasms - surgery | Ovarian Neoplasms - pathology | Carboplatin - administration & dosage | Fallopian Tube Neoplasms - pathology | Cytoreduction Surgical Procedures - methods | Disease-Free Survival | Peritoneal Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Fallopian Tube Neoplasms - surgery | Survival Analysis | Adult | Female | Neoadjuvant Therapy | Aged | Chemotherapy, Adjuvant | Paclitaxel - administration & dosage | Ovarian Neoplasms - drug therapy | Fallopian Tube Neoplasms - drug therapy | Ovarian Neoplasms - surgery | Oncology, Experimental | Adjuvant treatment | Laparoscopic surgery | Laparoscopy | Research | Comparative analysis | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights